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In vitro modulation of tubular cyst regression in murine polycystic
kidney disease. Recent studies in a murine model of genetically-
determined polycystic kidney disease, the CPK mouse, have suggested
that alterations in renal Na-K ATPase activity in concert with tubular
epithelial hyperplasia have pathogenic import in proximal tubular cyst
formation. In the current study, we therefore studied the relative roles
of Na-K ATPase activity, tubular epithelial hyperplasia, and basal
lamina alterations during in vitro modulation of proximal tubular cyst
regression during serum-free organ culture of newborn CPK kidneys.
Under basal in vitro conditions, regression of CPK proximal tubular
cysts was demonstrated in association with progressive decreases in
Na-K ATPase activity and tubular epithelial hyperplasia. The pattern of
proximal tubular cyst regression was modified by: a) Na-K ATPase
activity induction with triiodothyronine, which promoted proximal
tubular cystogenesis; and b) Na-K ATPase activity inhibition with
ouabain, which blocked the effects of T3 on the process of cyst
formation, Modulation of proximal tubular cystogenesis by Na-K
ATPase induction and inhibition were accomplished without significant
changes in proximal tubular epithelial hyperplasia or expression of
basal lamina components. We conclude that increased Na pump activ-
ity may have a significant role in proximal tubular cyst formation and
progressive enlargement in the CPK mouse,
Genetically determined human renal cystic diseases cause
major morbidity and mortality in all age groups [1, 2]. Autoso-
mal dominant polycystic kidney disease (ADPKD) alone affects
one in every 220 to 1000 individuals, and accounts for 8 to 10%
of all end-stage kidney disease [31. Although the causes of cyst
formation and progressive enlargement remain unknown, stud-
ies of human polycystic diseases to date demonstrate that cysts
retain certain functional characteristics of the discrete nephron
segments in which they arise, and function as "giant nephrons"
with high rates of fluid turnover [4, 51. It has thus been
suggested that active transepithelial secretion may have patho-
genic import in the basic process of renal cystogenesis [6—8].
In previous studies we have demonstrated that alterations in
renal Na-K adenosine triphosphatase (Na-K ATPase) activity
mediate proximal tubular cyst formation induced by cortisol or
triiodothyronine (T3) in renal organ culture [9, 10]. Similarly,
studies of a genetically-determined murine model of renal cystic
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disease, the CPK mouse, have demonstrated that initial in-
creases in Na-K ATPase activity and subsequent epithelial
hyperplasia parallel the course of proximal tubular cyst forma-
tion and growth in vivo [11]. We have postulated that in such
models, increased Na pump activity leads to alterations in
transtubular transport with resultant intratubular fluid accumu-
lation and cystic dilatation. Such transepithelial fluid secretion,
in concert with other pathogenic processes, such as tubular
epithelial hyperplasia or basal lamina alterations, could explain
the observed kinetics of cyst growth in a variety of experimen-
tal and human disease states [12].
In the current study we have further explored the relationship
between Na-K ATPase activity, epithelial hyperplasia and basal
lamina alterations in proximal tubular cyst formation in the
CPK mouse by utilizing in vitro organ culture methodology
[13—15]. Microexplants of control and CPK newborn kidneys
were cultured in serum-free, chemically-defined medium for 120
hours, and proximal tubular cyst regression and formation were
studied following specific Na-K ATPase stimulation and inhibi-
tion. Such studies suggest a significant role for Na-K ATPase
activity in proximal tubular cystogenesis in the CPK mouse.
Methods
Our basic method of serum-free organ culture of mouse
metanephros has been described in detail [9, 10, 13—16]. In the
current study, 140 to 160 pm explants of newborn control
C57B1/6J and cystic CPK kidneys were cultured in a Trowell-
type organ culture assembly, Basal culture medium was added
to the assemblies, and consisted of equal volumes of Dulbec-
co's modified Eagle's medium and Ham's F-l2 medium supple-
mented with: 10 mri N-2 hydroxyethylpiperazine-N'-2 ethane-
sulfonic acid buffer, 13.4 mM sodium bicarbonate, nystatin 50
U/mi, penicillin 50 U/ml, gentamicin 50 gIm1, transferrin 6.2><
M, prostaglandin E1 7.1 x io M, insulin 8.3 x lO" M,
and selenium 6.8 x l0 M. The completed organ culture
assemblies were incubated at 36 0.5°C and 95% humidity in a
mixed air-5% CO2 environment. Culture medium was com-
pletely changed every 24 hours. All culture medium was ob-
tained from Flow Laboratories, Inc. (McLean, Virginia, USA),
and all hormones were obtained as lyophilized tissue culture
reagents from Sigma Chemical Company (St. Louis, Missouri,
USA).
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In the current studies, specific protocols were utilized for the
induction and inhibition of Na-K ATPase in renal organ culture
explants. For ATPase induction, T3 at 2 x 10—8 Mwas added to
basal organ culture medium. T3 at 2 x 10_8 M was previously
shown to be a potent inducer of Na-K ATPase in metanephric
organ culture [10] and proved in preliminary in vitro studies of
CPK explants to be the optimal concentration for induction of
enzyme activity while minimizing deleterious effects on tissue
viability [17]. For ATPase inhibition, explants were incubated
for two hours daily in ouabain 2 x lO M (final concentration),
at 36 0.5°C in mixed air:5% CO2 at pH 7.30, and then returned
to basal culture conditions. This treatment protocol was devel-
oped following a series of previous organ culture studies of
ATPase inhibition [9, 10] and was effective in maximizing
ATPase inhibition and tissue viability in preliminary studies of
CPK organ explants [17].
The Na-K ATPase induction and inhibition protocols led to
the following six experimental groups for analysis: I) control; 2)
control + T3; 3) control + T3 + ouabain; 4) CPK; 5) CPK + T3;
and 6) CPK + T3 + ouabain. For each group, Na-K ATPase,
cystic indices, mitotic indices, and basal lamina glycoprotein
expression were determined prior to culture and following 72
and 120 hours of organ culture incubation. Further, organ
culture explants in all treatment groups were monitored daily
for growth and viability by standard histology and regular
determination of neutral red uptake and trypan blue exclusion
as previously described [13, 14, 161.
Histology and immunohistology
For each kidney explanted into organ culture, its paired mate
was processed for light microscopy and served as histologic
control. This assured clear recognition of cystic CPK kidneys
prior to culture. For all light microscopy, including repre-
sentative sampling of all tissue groups for viability as noted
above, tissue was fixed in 2% formaldehyde-2.5% glutaralde-
hyde, in phosphate buffer (pH 7.4) for two hours at 4°C. Tissue
was then washed, dehydrated through graded acetone, and
infiltrated and embedded with Immunobed plastic embedding
medium (Polysciences, Warrington, Pennsylvania, USA). Sec-
tions were cut on an ultramicrotome, mounted on glass slides,
and stained with hematoxylin.
In the current study, immunohistologic techniques were
applied to control and CPK explants to: 1) clearly localize
normal and cystic proximal tubular segments for quantitation of
cyst formation (cystic indices) and epithelial hyperplasia (mi-
totic labeling indices); and 2) characterize antigenic expression
of proximal tubular basal lamina components. The primary
antibody used for identifying proximal tubules was affinity-
purified antibody to the brush border enzyme, gamma-glutamyl
transpeptidase (y-GTP). Anti-y-GTP was provided by Dr. N.P.
Curthoys, Department of Micro-biology, Biochemistry, and
Molecular Biology, University of Pittsburgh School of Medi-
cine, and was prepared by his previously described methods
[181. Primary antibodies used for localization of basement
membrane glycoproteins included: 1) affinity-purified antibody
to heparan sulfate proteoglycan core protein, provided by Dr.
J.R. Hassell, Department of Ophthalmology, University of
Pittsburgh School of Medicine and prepared by his previously
published methods [19]; 2) affinity-purified antibody to entactin,
provided by Dr. A.E. Chung, Department of Biological Sci-
ences University of Pittsburgh, and prepared by his previously
described methods [20]; and 3) affinity-purified, anti-type IV
collagen; and anti-laminin and anti-fibronectin, obtained com-
mercially from the Pasteur Institute (Lyon, France) and Be-
thesda Research Laboratories (Gaithersburg, Maryland, USA),
respectively. All other antisera and sera were DAKO immuno-
chemicals, obtained through Accurate Chemical and Scientific
Corporation (Westbury, New York, USA).
The specific immunostaining procedure utilized was our
previously described post-embedding technique specifically de-
veloped for immunolocalization of basement membrane and
brush border antigens in plastic sections of fetal murine tissue
[10, 11, 21]. Trypsinized explant sections were incubated with
primary antibodies or pre-immune rabbit serum for 48 hours at
4°C, followed by sequential incubations with bridging swine
anti-rabbit IgG (1:20) and rabbit peroxidase-antiperoxidase
complex (1:100). In the current study, 8 to 14 control or CPK
explants of each treatment group were immunostained prior to
culture and following 72 and 120 hours of incubation with
anti-y-GTP 1:300, anti-heparan sulfate proteoglycan core pro-
tein 1:50, and anti-type IV collagen, anti-entactin, anti-laminin,
anti-fibronectin, and pre-immune rabbit serum, all at 1:200. In
addition to substitution of primary antibody with pre-immune
rabbit serum, controls included staining following absorption of
primary antibodies with purified antigens and deletion of spe-
cific reagents at each step of the procedure. In such controls, no
significant background staining was observed. All tubular stain-
ing for basal lamina components was graded semi-quantitatively
by a single observer (E.D.A) using the following scale: 0 = no
staining, 1 light focal or interrupted linear staining, 2 = light
linear staining, 3 = intense linear staining.
Immunoperoxidase stained sections were photographed with
an Olympus BH-2 photomicroscopy system equipped with an
Olympus PM-b exposure control unit on Ectachrome 100 ASA
daylight film (Kodak, Rochester, New York, USA) using a
KB-4 daylight balancing filter.
Determination of cystic and mitotic and labeling indices
The degree of proximal tubular cyst formation or regression
in explants was quantitated by utilization of the cystic index.
The index, derived from basic light microscopic morphometric
methods [221, has previously been standardized for quantitation
of cyst formation in organ culture sytems [9, 101. Following
routine histologic preparation, 6 to 10 serial 3 m sections of
intact explants were graded for cyst formation in tubular
segments expressing y-GTP on a scale of 0 (no cysts observed)
through 5 (multiple cysts greater than 0.20 mm) [9, 10]. The
proximal tubular cystic index for each explant was then deter-
mined by calculating means of the individual cyst scores. For
each treatment group, a cystic index was determined on a total
of 8 to 12 explants prior to culture and following 72 and 120
hours of incubation, and the results expressed as mean + range.
Epithelialhyperplasia of proximal tubules in each experimen-
tal group of control or CPK explants was determined by
calculation of proximal tubular cell mitotic indices and labeling
indices at eaëh developmental stage studied. Such indices have
been previously standardized for determination of epithelial
hyperplasia in experimental renal cystic disease [Il, 23, 24] and
other conditions [25], and successfully applied to fetal murine
tissue in previous organ culture studies [9, 10, 261. Indices were
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determined for each of 8 to 12 individual control or CPK
explants of each treatment group at each of the three develop-
mental stages studied. For mitotic indices, the number of
mitoses per 1000 proximal tubular cells was determined by
direct counting of cells comprising proximal tubular walls in
serial 3 m sections immunostained with anti-y-GTP and coun-
terstained with hematoxylin. The mitotic index was then de-
fined as the mean number of mitoses per 1000 proximal tubular
cells and calculated from the 6 to 10 determinations from each
explant. For labeling indices, explants were incubated with
3H-thymidine (New England Nuclear, Boston, Massachusetts,
USA, specific activity 20 Ci/mM) at a concentration of 0,2
pCi/mi under standard organ culture conditions for two hours.
Following timed incubations, explants were embedded and
serial 3 m sections were immunostained with anti-y-GTP.
Sections were then covered by dipping in photographic emul-
sion (Kodak NTB2) and exposed for three to four weeks at 4°C.
After exposure, sections were developed in Kodak D19, fixed in
ammoniurn thiosuiphate and stained with hematoxylin. The
labeling index was then defined as the mean number of 3H-
thymidine labeled (5 nuclear silver grains) epithelial cells per
1000 total epithelial cells in defined proximal tubular segments,
and calculated from the six to ten determinations from each
explant.
ATPase determination
Na-K ATPase was determined in control and CPK explants
by our previously described modification of the linked pyru-
vate kinase-tactate dehydrogenase kinetic spectrophotometric
method [9—11, 27]. Explant homogenates were added to dupli-
cate cuvettes containing the reaction mixture and two addi-
tional cuvettes containing ouabain, 2.5 mmol/liter (final concen-
tration), in addition to the reaction mixture. The reaction
mixture contained (final concentration) 100 mmoi/liter NaCI, 10
mmollliter KCI, 2.5 mmol/iiter MgCI2, 1 mmol/liter Tris-ATP, 1
mmollliter tri(cyclohexylammonium)phosphoenolpyruvate, 30
mmol/liter imidazole-HCI buffer (pH 7.3), 0.15 mmol/liter
NADH, 50 g/ml of lactate dehydrogenase, and 30 rg/m1 of
pyruvate kinase. ATPase was calculated from the oxidation of
NADH by use of a Perkin-Elmer Lambda 3 spectrophotometer
(Perkin-Elmer Corp., Norwalk, Connecticut, USA) and the
L3CP kinetic software program of the Perkin-Elmer 3600 Data
Station, and expressed as micromoles per minute per micro-
gram of tissue DNA as assayed by the fluorimetric method of
Nordling and Aho [28]. Specific Na-K ATPase was determined
as ouabain-sensitive ATPase and computed as the difference
between the reaction rate with and without the addition of
ouabain, 2.5 mmol/liter (final concentration). As noted previ-
ously, this concentration of ouabain is 10 times the concentra-
tion required for maximal inhibition of ATPase in murine fetal
or adult kidney homogenates [9].
Enzyme activity was expressed as the mean value of six
homogenates from each experimental group of control or CPK
explants prior to culture and following 72 and 120 hours of
organ culture incubation. Each tissue homogenate represented
a total of six to ten explants.
Statistical methods
All parametric data (including Na-K ATPase, and mitotic and
labeling indices) were expressed as mean SD, and significant
differences of means determined by Student's t-test. The cystic
indices, as nonparametric data, were expressed as means with
ranges, and significance of differences between groups deter-
mined by the Wilcoxon rank sum test [29].
Results
Organ culture morphology
In the current study, the morphological development of
control and CPK microslices during 120 hours of in vitro
incubation in basal medium was similar to that previously
described [15]. In basal medium, control explants demonstrated
continuing nephrogenesis with advanced tubulogenesis and
ureteric bud branching during organ culture incubation. The
morphology of control explants incubated in T3-supplemented,
or T3 + ouabain-supplemented medium could not be differen-
tiated from explants incubated in basal medium. In addition, no
proximal tubular cystic abnormalities were observed in any
treatment group of control explants at any stage of incubation
(Table 1). At the time of explantation into culture, newborn
CPK explants showed tubular dilatation, cyst formation, and
epithelial hyperplasia against a background of normal nephro-
genesis (Fig. 1A, Table 1). In accord with previously reported
data [30, 31], greater than 95% of the cystic lesions present at
this developmental stage were localized to proximal tubules by
positive immunohistologic staining for the brush border anti-
gen, y-GTP. During 120 hours of incubation in basal medium
there was a striking regression of proximal tubular cystic
lesions and a decrease in tubular epithelial hyperplasia (Fig. IB,
Table 1). The addition ofT3 to basal medium of CPK explants
prevented significant in vitro regression of proximal tubular
cysts during incubation (Fig. 1C, Table 1), while the addition of
T1 + ouabain promoted proximal tubular cyst regression which
could not be differentiated from CPK explants cultured in
unsupplemented basal medium (Fig. 1D; Table 1). The proximal
tubular location of all cystic lesions noted in CPK explants
grown in T3-supplemented basal medium was confirmed by
positive immunostaining for y-GTP.
The addition ofT3 or T3 + ouabain to basal medium of either
control or CPK tissue was not associated with morphologic
evidence of tissue disruption or abnormal differentiation in
explants. Cellular viability in all treatment groups remained
above 91% following 72 hours of culture, and above 84%
following 120 hours of culture.
Na-K ATPase activity
Explant Na-K ATPase activity following the proscribed
series of in vitro incubations is shown in Table 1. In control
tissue, Na-K ATPase activity was not significantly different
from pre-culture explants following 72 hours of culture, but was
decreased by 120 hours of incubation. The addition of T3 to
basal medium of control tissue prevented any significant decline
in Na-K ATPase levels during the 120-hour culture period. Prior
to culture, newborn CPK explants demonstrated significantly
increased Na-K ATPase activity relative to controls as previ-
ously described [111. Under basal in vitro conditions, there
were significant decreases in explant Na-K ATPase following 72
and 120 hours of culture. The addition of T3 to basal medium of
CPK explants attenuated the decrease in Na-K ATPase at both
72 and 120 hours in vitro (Table 1).
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Table 1. In vitro modulation of tubular cyst formation
Proximal tubular Na-K ATPase activity Proximal tubular Proximal tubular
cystic index nmoI min' pg DNA-' mitotic index labelling index
Treatment group/conditions
Pre-culture:
Control 0 0.40 0.01 27.87 1.69 35.86 3.94
CPK 434 (3.71—4.83) 0.62 0.02 36.49 2.71" 69.72 6.l2a
Post-culture, 72 hours:
Control 0 0.34 0.02 24.31 4.21 33.94 3.56
Control + T3
Control + T3 + ouabain
CPK
0
0
l.44a.c (0.85—3.25)
0.36 0.04
0.33 0.03c
23.86 3.24
19.24 3.67
22.83 2.92"
38.54 4.82
30.30 5.48
45.41 8.90"
CPK + T3
CPK + T3 + ouabain
3,9la (2.58—4.42)
l.21a.C (0.41—2.98)
0.42 002b,d 23.16 3.04"
23.72 412d
47.12 6.14"
43.48 612d
Post-culture, 120 hours:
Control 0 0.29 O.O3 22.51 3.21 35.06 5.70
Control + T3 0 0.35 0.02 20.63 2.O6 39.36 5.05
Control + T3 + ouabain
CPK
0
0.39c (0—0.57) 0.31 0.02c
18.41 l.64e
21.58 4.61"
35.84 4.26
42.14 5.40'
CPK + T3
CPK + T3 + ouabain
3.89a (3.13—4.21)
0.54c (0—0.92)
0.43 0.03" 19.16 2.48c
20.97 2.19"
47.36 512d
40,61 5.23c
P < 0.001 vs. control (at same stage of incubation)b P < 0.01 vs. control (at same stage of incubation)
P < 0.001 vs. CPK pre-culture
' P < 0.01 vs. CPK pre-culture
e P < 0.001 vs. control pre-culture
P < 0.01 vs. control pre-culture
Epithelial hyperplasia and basal lamina alterations during
organ culture
Changes in proximal tubular epithelial hyperplasia in control
and CPK explants under the experimental protocols of proximal
tubular cyst modulation are demonstrated in Table 1. Prior to
culture, cystic proximal tubules of newborn CPK explants
showed increased proximal tubular mitotic indices and labeling
indices relative to controls, as previously described [11]. Con-
trol tissue incubated in basal medium showed no significant
change in proximal tubular epithelial hyperplasia during the
120-hour incubation period. The addition ofT3 to basal medium
had no effect on the mitotic or labeling index of control explants
at 72 hours post-culture, but was associated with a decreased
mitotic index by 120 hours in vitro. The daily treatment of
T3-supplemented control tissue with ouabain was associated
with decreased tubular epithelial mitotic indices at both 72 and
120 hours of incubation.
CPK explants showed a significant decrease in both proximal
tubular mitotic indices and labeling indices at both 72 and 120
hours when cultured under basal conditions. T3 supplementa-
tion of basal medium had no perceptible effect on the in vitro
decline of proximal tubular epithelial hyperplasia in CPK ex-
plants (Table 1). Similarly, daily treatment of T3-supplemented
CPK tissue with ouabain had no demonstrable effect on the
decreased proximal tubular mitotic and labeling indices at 72
and 120 hours in vitro. Explants demonstrated minor changes in
proximal tubular basal lamina heparan sulfate proteoglycan
core protein, entactin, type IV collagen, laminin, or fibronectin
expression during 120 hours of organ culture under all of the
experimental protocols (Table 2, Fig. 2). Prior to culture, basal
lamina expression of all studied components was graded 2+ to
3 + in cystic proximal tubules of CPK kidneys as well as control
proximal tubules [11] (Table 2, Fig. 2 A and B). During 120
hours of culture, control tissue under basal conditions or
following T3, or T3 + ouabain treatment, demonstrated slight
decreases in the intensity of immunoperoxidase staining for all
basal lamina components (Table 2; Fig. 2 C and E). Staining
remained linear and 2+ in intensity for all control tissue
regardless of incubation conditions. Similarly, CPK tissue
incubated in basal medium alone or supplemented with T3 or T3
+ ouabain showed minimal alterations in immunoperoxidase
staining of cystic proximal tubules for heparan sulfate proteo-
glycan core protein, entactin, type IV collagen laminin or
fibronectin during organ culture which were indistinguishable
from controls from each experimental incubation. (Table 2; Fig.
2 D and F).
Discussion
Studies of the ontogeny of cyst formation in the CPK mouse
model have demonstrated two distinct phases of cystic nephron
involvement [11,30,31]. Initially, cystic lesions are localized to
the distal portions of developing proximal tubules. Subse-
quently, with disease progression, there is a shift in the site of
predominant cystic nephron involvement from proximal tubules
to collecting tubules without involvement of other nephron
segments. To identify specific cystogenic factors operative in
the earliest stages of this genetically determined murine poly-
cystic kidney disease, we have previously focused on the
process of proximal tubular cyst formation. Studies to date
have demonstrated that: a) ultrastructural features suggesting
increased transtubular transport attend the earliest stages of
proximal tubular cyst formation [3 l}; b) increased renal Na-K
ATPase activity parallels the course of proximal tubular cyst
formation and progression [11]; and c) tubular epithelial hyper-
plasia, but not altered basal lamina glycoprotein expression, is
a consistent feature of progressive proximal tubular cystic
enlargement [11, 31]. The current study confirms, and expands
these observations by utilizing in vitro organ culture methodol-
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Fig. 1. Explants of kidneys from newborn CPK mice. A. Prior to culture, CPK kidneys demonstrated tubular dilatation and cyst formation with
good preservation of overall renal architecture (Hematoxylin x 30). B. Following 120 hours of organ culture incubation in basal medium, there was
a regression of proximal tubular cystic lesions against a background of normal nephrogenesis (Hematoxylin x 60). C. Culture of CPK explants for
120 hours in medium containing T3 (2 x 10—8 M) supported proximal tubular cyst formation (Hematoxylin x60). D. Daily ouabain treatment of CPK
explants cultured in T3-supplemented medium for 120 hours promoted proximal tubular cyst regression, which was similar to that seen in CPK
explants cultured in basal medium (compare with B) (Hematoxylin x99).
ogy which permits experimental manipulation of cyst formation
under highly controlled conditions [9, 10, 151. Under organ
culture conditions, stimulation and inhibition of renal Na-K
ATPase activity modulates CPK proximal tubular cyst forma-
tion without significant effects on tubular epithelial hyperplasia
or the expression of a variety of basal lamina components.
Following incubation in basal medium, control explants
showed a gradual decline in Na-K ATPase activity which was
prevented by supplementation of medium with T3 for 120 hours
(Table 1). Such data confirm the previously described effect of
T3 on Na-K ATPase induction in renal tissue [10, 32—341, and
suggest, as in fetal tissue, that small quantities of T3 may be
required for optimal growth, development, and metabolism of
explants from newborn murine kidneys [13, 14, 35]. CPK
explants incubated in basal medium demonstrated a marked
decrease in Na-K ATPase activity which paralleled the progres-
sive in vitro regression of cystic proximal tubular changes
(Table 1). T3 stimulation of Na-K ATPase activity in CPK
explants was associated with the preservation of proximal
tubular cysts, and inhibition of Na-K ATPase activity with
ouabain correspondingly permitted proximal tubular cyst re-
gression. The direct modulation of proximal tubular cyst regres-
sion and formation by experimental manipulation of renal Na-K
ATPase activity suggests an association between proximal
tubular cyst formation and sodium pump activity in the CPK
mouse. Such data expands previous in vivo and in vitro data
relating proximal tubular cyst formation to Na-K ATPase
activity in both naturally-occurring murine polycystic kidney
B
p
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Table 2. In vitro proximal tubular basal Iamina immunostaining
Heparan sulfate
proteoglycan Type IV
core protein Entactin collagen Laminin Fibronectin
Pre-culture
Control 3 + 2—3+ 3+ 3+ 2—3+
CPK 3+ 2-3+ 3+ 3+ 2-3+
Post-culture, 120 hours
Control 2+ 2+ 2—3+ 2+ 2+
Control + T3 2+ 2+ 2—3+ 2—3+ 2+
Control + T3 + ouabain 2+ 2+ 2+ 2+ 2+
CPK 2+ 2+ 2-3+ 2+ 2+
CPK + T3 2+ 2+ 2-3+ 2-3+ 2+
CPK + 'F3 + ouabain 2+ 2+ 2+ 2+ 2+
Semiquantitative immunoperoxidase staining 0 —p 3+ (see Methods for details).
disease, as well as chemically-induced organ culture models of
cyst formation [9—11].
While control tissue demonstrated no significant changes in
proximal tubular epithelial hyperplasia during incubation in
basal medium, CPK explants demonstrated a progressive de-
crease in proximal tubular mitotic and labeling indices during
such incubation, which paralleled the regression of proximal
tubular cystic changes and decreasing Na-K ATPase activity
(Table 1). Such results confirm previous data suggesting a
relationship between epithelial hyperplasia and progressive
proximal tubular cystic enlargement during cyst ontogeny in the
CPK mouse [11, 31]. T3 treatment of either control or CPK
explants did not increase proximal tubular mitotic or labeling
indices. Thus, in CPK explants, proximal tubular cyst forma-
tion and increased explant Na-K ATPase activity were disso-
ciated from proximal tubular epithelial hyperplasia. These
findings support previous data suggesting that T3 is not a major
mitogen for developing murine renal epithelial cells [14]. De-
spite inhibition of cyst formation, ouabain treatment did not
significantly affect proximal tubular mitotic or labeling indices
(Table 1). The current data confirm previous organ culture
observations that in vitro proximal tubular cyst formation can
occur without significant epithelial hyperplasia [9, 101. This
suggests that tubular secretion and epithelial hyperplasia are
independent cystogenic processes which may be separated
under certain experimental conditions. Organ culture modula-
tion of CPK proximal tubular cyst formation thus provides a
unique opportunity to isolate and study the specific transport
processes operative in proximal tubular cyst formation.
All cultured tissue showed minor decreases in the intensity of
immunoperoxidase staining for proximal tubular basal lamina
components. However, organ culture modulation of proximal
tubular cyst formation in the CPK mouse was not associated
with alterations in the expression of any specific basal lamina
components when compared with controls. Though limited by
the semi-quantitative nature of the immunoperoxidase methoei
ology employed, the current study is consistent with previous
ultrastructural and immunohistologic analyses which revealed
no consistent abnormalities of proximal tubular basal lamina in
CPK kidneys at various stages of nephron development in vivo
[11, 31]. This suggests that basal lamina alterations, considered
to be important pathogenic factors in certain toxin-induced
cystic models [35—37] may not be significant factors in CPK
proximal tubular cyst formation. The current study supports
recent data showing no abnormalities in the visco-elasticity of
CPK cystic tubular basal laminae [39], and confirms the recent
immunohistological findings of Ebihara et al [40], who found no
differences in immunofluorescent staining for type IV collagen,
laminin and heparan sulfate proteoglycan in CPK tubular cyst
walls from seven-day-old animals when compared to controls.
The same authors, however, found focal decreases in basement
membrane antigen expression in enlarged cysts of two- and
three-week old CPK kidneys. Further, at all stages studied,
immunofluorescence findings were inversely correlated with
whole kidney mRNA levels for type IV collagen and laminin
[40]. Such studies suggest that abnormal regulation of basal
lamina gene transcription and/or translation may have patho-
genic significance during the later stages of cyst formation in
CPK kidneys when disease is prominent in collecting tubules
[31]. Additional studies analyzing qualitative and quantitative
changes in collagen, glycoprotein, and proteoglycan composi-
tion of CPK cystic tubular basal lamina in discrete nephron
segments at various stages of the disease process will help to
further clarify this issue.
Although establishing a relationship between whole explant
Na-K ATPase activity and in vitro modulation of proximal
tubular cyst regression, the current study does not localize the
observed changes in transport enzyme activity to specific
proximal tubular segments. However, recent preliminary data
from our laboratory demonstrate increased Na-K ATPase ac-
tivity in morphologically normal as well as cystic proximal
tubules isolated from CPK kidneys by density gradient centrif-
ugation [411. The current study does not identify the precise
manner by which increased Na-K ATPase activity might pro-
mote proximal tubular cyst formation in the CPK mouse. We
have previously hypothesized that sodium pump mediated
alterations in transtubular transport resulting in net fluid secre-
tion and intratubular fluid accumulation were pathogenic fea-
tures of proximal tubular cyst formation in CPK kidneys [11,
31]. The current study supports this hypothesis in that in the
non-perfused, non-filtering organ culture system, tubular dila-
tation could occur if net fluid secretion occurred in proximal
tubular segments that were functionally obstructed by stasis. If
the Na-K ATPase is oriented normally at the basolateral surface
in proximal tubular cyst walls of CPK explants, net fluid
secretion with luminal dilatation could occur through sodium-
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Fig. 2. Explants of newborn control and CPK mice immunostained with anti-heparan sulfate proteoglycan core protein, 1:50. Tubular
immunostaining patterns with anti-entactin 1:200, anti-type IV collagen 1:200, anti-laminin 1:200, and anti-fibronectin 1:200 were similar (Table 2).
A. Control kidney prior to culture demonstrates intense linear basal staining (3+) of all recognizable tubular forms throughout the tissue section.
Also noted is glomerular epithelial staining. B. Newborn CPK explant demonstrates basal staining of cystic as well as unaffected tubules.
Localization and intensity (3+) of immunostaining are similar to that noted in controls (A). C. Control explant following 120 hours of incubation
in basal medium demonstrates a slight decrease in the intensity of immunological expression (2+) of tubular basal lamina components. D. Following
incubation for 120 hours in basal medium, CPK explant demonstrates regression of proximal tubular cysts without changes in localization or
intensity (2+) of tubular basal lamina staining as compared to in vitro control (C). E. Control explant following 120 hour incubation in medium
containing T3 (2 >< 10_8 M) shows no morphologic abnormalities of tubules which maintain linear (2+) basal lamina immunostaining. F. Following
incubation for 120 hours in medium containing T3 (2 x l08 M) both cystic and morphologically-normal proximal tubules of CPK explants
demonstrate basal tubular immunostaining similar in intensity (2+) and localization to identically treated in vitro controls (E). All figures are
immunoperoxidase, counterstained with hematoxylin; 230x.
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linked counter-transport of an impermeant solute into tubular
lumina [42, 431. The net intraluminal accumulation and trapping
of an actively transported osmol would promote net intratubu-
lar fluid accumulation and provide hydrostatic forces favoring
cystic dilatation [44]. Preliminary studies indicate that such a
process, involving sodium pump mediated organic anion secre-
tion, is operative during in vitro modulation of proximal tubular
cyst regression in CPK explants [45]. During CPK proximal
tubular cyst formation in vivo, fluid secretion in concert with
epithelial hyperplasia [11, 31] would be sufficient to explain the
mathematically-modeled kinetics of tubular cyst growth [12].
Additional studies of enzyme determination and transport in
isolated, defined tubular segments at various stages of CPK
nephrogenesis will be required to establish a direct relationship
between altered Na-pump activity, specific transport processes,
and cyst formation in specific nephron segments of CPK
kidneys.
The relationship of increased Na-K ATPase activity and
modulation of proximal tubular cyst formation in CPK explants
to CPK collecting tubule cyst formation or the overall patho-
genesis of cyst formation in human disease states is unclear
[11]. Although renal Na-K ATPase activity has not been di-
rectly determined in human polycystic diseases, recent studies
suggest a possible role for altered transtubular transport in both
autosomal dominant polycystic kidney disease (ADPKD) and
acquired renal cystic disease of the end-stage kidney. Wickre
and Bennett studied cystic epithelial transport of organic mol-
ecules in a non-uremic patient with ADPKD, and concluded
that active basolateral transport of endogenous anions plays a
role in the process of cyst growth [46]. Further, on the basis of
a systematic scanning electron microscopic study of 387 cysts
from 10 patients with ADPKD, Grantham, Geiser and Evan
concluded that sequestration of fluid delivered to cysts by
transepithelial secretion, in combination with sustained epithe-
hal hyperplasia, was a major determinant of cyst enlargement
[47]. Of particular note in this regard is the recent report of
increased Na-K ATPase activity by cytochemical staining of
epithelial cells cultured from the cyst walls of ADPKD kidneys
[48]. Finally, on the basis of a series of transport studies in
isolated rabbit proximal tubules, Grantham suggested that net
tubular fluid secretion driven by organic anion transport ac-
counts for the widely dilated proximal tubules commonly ob-
served in end-stage kidneys and may have similar pathogenic
import in cyst formation and/or progressive enlargement in
acquired multicystic disease of dialysis patients [6, 49]. Further
characterization of altered epithelial transport in CPK proximal
tubular cyst formation may provide additional insight into the
complex pathogenesis of renal cyst formation and progressive
enlargment in human disease states.
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